1. Home
  2. IRTC vs BTG Comparison

IRTC vs BTG Comparison

Compare IRTC & BTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRTC
  • BTG
  • Stock Information
  • Founded
  • IRTC 2006
  • BTG 2006
  • Country
  • IRTC United States
  • BTG Canada
  • Employees
  • IRTC N/A
  • BTG N/A
  • Industry
  • IRTC Medical/Dental Instruments
  • BTG Precious Metals
  • Sector
  • IRTC Health Care
  • BTG Basic Materials
  • Exchange
  • IRTC Nasdaq
  • BTG Nasdaq
  • Market Cap
  • IRTC 3.1B
  • BTG 3.4B
  • IPO Year
  • IRTC 2016
  • BTG N/A
  • Fundamental
  • Price
  • IRTC $100.96
  • BTG $3.32
  • Analyst Decision
  • IRTC Strong Buy
  • BTG Buy
  • Analyst Count
  • IRTC 10
  • BTG 3
  • Target Price
  • IRTC $120.20
  • BTG $4.12
  • AVG Volume (30 Days)
  • IRTC 365.8K
  • BTG 49.9M
  • Earning Date
  • IRTC 05-01-2025
  • BTG 05-07-2025
  • Dividend Yield
  • IRTC N/A
  • BTG 4.22%
  • EPS Growth
  • IRTC N/A
  • BTG N/A
  • EPS
  • IRTC N/A
  • BTG N/A
  • Revenue
  • IRTC $591,839,000.00
  • BTG $1,902,030,000.00
  • Revenue This Year
  • IRTC $17.46
  • BTG $44.42
  • Revenue Next Year
  • IRTC $16.93
  • BTG $1.64
  • P/E Ratio
  • IRTC N/A
  • BTG N/A
  • Revenue Growth
  • IRTC 20.13
  • BTG N/A
  • 52 Week Low
  • IRTC $55.92
  • BTG $2.20
  • 52 Week High
  • IRTC $128.52
  • BTG $3.51
  • Technical
  • Relative Strength Index (RSI)
  • IRTC 46.56
  • BTG 62.28
  • Support Level
  • IRTC $98.41
  • BTG $3.18
  • Resistance Level
  • IRTC $104.12
  • BTG $3.51
  • Average True Range (ATR)
  • IRTC 6.10
  • BTG 0.19
  • MACD
  • IRTC -0.15
  • BTG 0.04
  • Stochastic Oscillator
  • IRTC 50.18
  • BTG 80.61

About IRTC iRhythm Technologies Inc.

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

About BTG B2Gold Corp Common shares (Canada)

B2Gold Corp is an international, low-cost, senior gold mining company. It has three operating open-pit gold mines in Mali, Namibia, and the Philippines and numerous exploration projects across four continents. Other assets include the Gramalote and Kiaka gold projects. The company focuses on acquiring and developing interests in mineral properties with a primary focus on gold deposits as gold production forms all its revenue. There is no dependence on a particular purchaser because the gold is sold into various markets. The company's reportable operating segments include its mining operations and development projects, namely Fekola; Masbate; Otjikoto; the Goose Project, and other mineral properties; and corporate and other.

Share on Social Networks: